We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ZEAL.CO

Price
428.90
Stock movement up
+20.50 (5.02%)
Company name
Zealand Pharma A/S
Exchange
(CO
,
Currency
DKK
)
Sector
Healthcare >
Biotechnology
Market cap
30.30B
Ent value
30.54B
Price/Sales
394.18
Price/Book
3.41
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
69.86
PEG
-
EPS growth
-
1 year return
-30.03%
3 year return
56.83%
5 year return
12.92%
10 year return
15.56%
Last updated: 2025-04-11

DIVIDENDS

ZEAL.CO does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales394.18
Price to Book3.41
EV to Sales397.24

FINANCIALS

Per share

Per share data
Current share count70.65M
EPS (TTM)-14.90
FCF per share (TTM)-10.07

Income statement

Income statement data
Revenue (TTM)76.87M
Gross profit (TTM)48.77M
Operating income (TTM)-1.12B
Net income (TTM)-1.05B
EPS (TTM)-14.90
EPS (1y forward)6.14

Margins

Margins data
Gross margin (TTM)63.45%
Operating margin (TTM)-1450.97%
Profit margin (TTM)-1369.25%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash511.02M
Net receivables207.00K
Total current assets8.72B
Goodwill0.00
Intangible assets0.00
Property, plant and equipment128.92M
Total assets9.63B
Accounts payable229.70M
Short/Current long term debt389.49M
Total current liabilities245.63M
Total liabilities746.69M
Shareholder's equity8.88B
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-690.82M
Capital expenditures (TTM)20.54M
Free cash flow (TTM)-711.37M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-11.85%
Return on Assets-10.93%
Return on Invested Capital-11.47%
Cash Return on Invested Capital-7.75%

STOCK INFORMATION

Stock chart

Stock price data
Open484.00
Daily high484.00
Daily low427.60
Daily Volume435K
All-time high954.00
1y analyst estimate1017.92
Beta0.54
EPS (TTM)-14.90
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Downside potential data
ZEAL.COS&P500
Current price drop from All-time high-55.04%-14.41%
Highest price drop-75.53%-56.47%
Date of highest drop16 May 20229 Mar 2009
Avg drop from high-27.70%-11.07%
Avg time to new high35 days12 days
Max time to new high973 days1805 days
COMPANY DETAILS
ZEAL.CO (Zealand Pharma A/S) company logo
Marketcap
30.30B
Marketcap category
Large-cap
Description
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company offers Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon that is in Phase III clinical trials for treating congenital hyperinsulinism. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark.
Employees
298
Website
https://www.zealandpharma.com
Investor relations
-
SEC filings
ZEAL.CO SEC filings
CEO
Country
Denmark
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved